2E,6E-farnesol

2e,6e-farnesol is a lipid of Prenol Lipids (PR) class. 2e,6e-farnesol is associated with abnormalities such as Granulomatous Disease, Chronic, pathologic fistula and Cavitation. The involved functions are known as Regulation, Metabolic Inhibition, cholesterol biosynthetic process, Process and Transcription, Genetic. 2e,6e-farnesol often locates in Plasma membrane, Cytoplasmic matrix, cornified envelope, Epidermis and peroxisome. The associated genes with 2E,6E-farnesol are RAB3A gene, FOSL1 gene, CASP8AP2 gene, RCC1 gene and GALE gene. The related lipids are Sterols, Membrane Lipids and Steroids.

Cross Reference

Introduction

To understand associated biological information of 2E,6E-farnesol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2E,6E-farnesol?

2E,6E-farnesol is suspected in Granulomatous Disease, Chronic, pathologic fistula and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2E,6E-farnesol

MeSH term MeSH ID Detail
HIV Infections D015658 20 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Neurilemmoma D009442 10 associated lipids
Head Injuries, Closed D016489 5 associated lipids
Insulin Resistance D007333 99 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Neuralgia D009437 28 associated lipids
Lung Injury D055370 14 associated lipids
Neoplasms, Glandular and Epithelial D009375 12 associated lipids
Nerve Sheath Neoplasms D018317 4 associated lipids
Per page 10 20 50 | Total 42

PubChem Associated disorders and diseases

What pathways are associated with 2E,6E-farnesol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2E,6E-farnesol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 2E,6E-farnesol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 2E,6E-farnesol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 2E,6E-farnesol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 2E,6E-farnesol?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2E,6E-farnesol

Download all related citations
Per page 10 20 50 100 | Total 950
Authors Title Published Journal PubMed Link
Chen M et al. Use of synthetic isoprenoids to target protein prenylation and Rho GTPases in breast cancer invasion. 2014 PLoS ONE pmid:24587105
Ha J et al. Determination of E,E-farnesol in Makgeolli (rice wine) using dynamic headspace sampling and stir bar sorptive extraction coupled with gas chromatography-mass spectrometry. 2014 Food Chem pmid:24001815
Ling Y et al. Synthesis and biological evaluation of farnesylthiosalicylamides as potential anti-tumor agents. 2014 Bioorg. Med. Chem. pmid:24300920
Okamoto S et al. Zoledronic acid induces apoptosis and S-phase arrest in mesothelioma through inhibiting Rab family proteins and topoisomerase II actions. 2014 Cell Death Dis pmid:25393473
Goldshmit Y et al. Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma. 2014 Oncotarget pmid:25261371
Zhang X et al. Reduction-sensitive dual functional nanomicelles for improved delivery of paclitaxel. 2014 Bioconjug. Chem. pmid:25121577
Zhang X et al. PEG-farnesyl thiosalicylic acid telodendrimer micelles as an improved formulation for targeted delivery of paclitaxel. 2014 Mol. Pharm. pmid:24987803
Ilayaraja R et al. Evaluating the binding efficiency of pheromone binding protein with its natural ligand using molecular docking and fluorescence analysis. 2014 Sci Rep pmid:24903953
Chen Y et al. Targeted delivery of curcumin to tumors via PEG-derivatized FTS-based micellar system. 2014 AAPS J pmid:24706375
Schmukler E et al. Chloroquine synergizes with FTS to enhance cell growth inhibition and cell death. 2014 Oncotarget pmid:24368422
Cotoras M et al. Farnesol induces apoptosis-like phenotype in the phytopathogenic fungus Botrytis cinerea. 2013 Jan-Feb Mycologia pmid:22962358
Alves FR et al. Biofilm biomass disruption by natural substances with potential for endodontic use. 2013 Jan-Feb Braz Oral Res pmid:23306623
de Oliveira Júnior WM et al. Farnesol: antinociceptive effect and histopathological analysis of the striatum and hippocampus of mice. 2013 Fundam Clin Pharmacol pmid:22340189
Cordeiro RA et al. Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against Candida species are reduced by farnesol. 2013 Med. Mycol. pmid:22712455
Farag MA and Al-Mahdy DA Comparative study of the chemical composition and biological activities of Magnolia grandiflora and Magnolia virginiana flower essential oils. 2013 Nat. Prod. Res. pmid:22690913
Zhang X et al. PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel. 2013 Bioconjug. Chem. pmid:23425093
Brilhante RS et al. Effect of farnesol on growth, ergosterol biosynthesis, and cell permeability in Coccidioides posadasii. 2013 Antimicrob. Agents Chemother. pmid:23459491
Mor A et al. Immunomodulatory properties of farnesoids: the new steroids? 2013 Curr. Med. Chem. pmid:23432580
Langford ML et al. Candida albicans Czf1 and Efg1 coordinate the response to farnesol during quorum sensing, white-opaque thermal dimorphism, and cell death. 2013 Eukaryotic Cell pmid:23873867
Schmukler E et al. Ras inhibition enhances autophagy, which partially protects cells from death. 2013 Oncotarget pmid:23847721
Wang C et al. Engineered heterologous FPP synthases-mediated Z,E-FPP synthesis in E. coli. 2013 Metab. Eng. pmid:23608473
Cho SW et al. Positive regulation of osteogenesis by bile acid through FXR. 2013 J. Bone Miner. Res. pmid:23609136
Gouveia V et al. Di- and sesquiterpenoids from Cystoseira genus: structure, intra-molecular transformations and biological activity. 2013 Mini Rev Med Chem pmid:23621654
Rivera-Perez C et al. Aldehyde dehydrogenase 3 converts farnesal into farnesoic acid in the corpora allata of mosquitoes. 2013 Insect Biochem. Mol. Biol. pmid:23639754
Jones S et al. β-ionone induces cell cycle arrest and apoptosis in human prostate tumor cells. 2013 Nutr Cancer pmid:23659452
Szűcs G et al. Cardioprotection by farnesol: role of the mevalonate pathway. 2013 Cardiovasc Drugs Ther pmid:23673412
Charette N et al. Salirasib sensitizes hepatocarcinoma cells to TRAIL-induced apoptosis through DR5 and survivin-dependent mechanisms. 2013 Cell Death Dis pmid:23348585
Schmukler E et al. Ras inhibition enhances autophagy, which partially protects cells from death. 2013 Oncotarget pmid:23370967
Kraitzer A et al. Mechanisms of antiproliferative drug release from bioresorbable porous structures. 2013 J Biomed Mater Res A pmid:23065767
Barkan B et al. Ras inhibition boosts galectin-7 at the expense of galectin-1 to sensitize cells to apoptosis. 2013 Oncotarget pmid:23530091
Faigenbaum R et al. Growth of poorly differentiated endometrial carcinoma is inhibited by combined action of medroxyprogesterone acetate and the Ras inhibitor Salirasib. 2013 Oncotarget pmid:23530112
Xu H et al. Glucanase induces filamentation of the fungal pathogen Candida albicans. 2013 PLoS ONE pmid:23737947
Nunes PM et al. Study of trans-trans farnesol effect on hyphae formation by Yarrowia lipolytica. 2013 Bioprocess Biosyst Eng pmid:23715764
Nyati P et al. Farnesyl phosphatase, a Corpora allata enzyme involved in juvenile hormone biosynthesis in Aedes aegypti. 2013 PLoS ONE pmid:23940797
Onono F et al. Efficient use of exogenous isoprenols for protein isoprenylation by MDA-MB-231 cells is regulated independently of the mevalonate pathway. 2013 J. Biol. Chem. pmid:23908355
Schokoroy S et al. Disrupting the oncogenic synergism between nucleolin and Ras results in cell growth inhibition and cell death. 2013 PLoS ONE pmid:24086490
Kloog Y et al. Ras chaperones: new targets for cancer and immunotherapy. 2013 Enzymes pmid:25033809
Pfister C et al. Detection and quantification of farnesol-induced apoptosis in difficult primary cell cultures by TaqMan protein assay. 2013 Apoptosis pmid:23315006
Cerca N et al. Farnesol induces cell detachment from established S. epidermidis biofilms. 2013 J. Antibiot. pmid:23549353
Kuete V and Efferth T Molecular determinants of cancer cell sensitivity and resistance towards the sesquiterpene farnesol. 2013 Pharmazie pmid:23923645
Alves FR et al. Antibiofilm and antibacterial activities of farnesol and xylitol as potential endodontic irrigants. 2013 Braz Dent J pmid:23969910
Lazzerini PE et al. Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. 2013 Joint Bone Spine pmid:22999910
Wang X et al. Waikialoid A suppresses hyphal morphogenesis and inhibits biofilm development in pathogenic Candida albicans. 2012 J. Nat. Prod. pmid:22400916
Goldberg L et al. FTS and 2-DG induce pancreatic cancer cell death and tumor shrinkage in mice. 2012 Cell Death Dis pmid:22419113
Green SA et al. Identification, functional characterization, and regulation of the enzyme responsible for floral (E)-nerolidol biosynthesis in kiwifruit (Actinidia chinensis). 2012 J. Exp. Bot. pmid:22162874
Yu LH et al. Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm. 2012 Antimicrob. Agents Chemother. pmid:22106223
Oron T et al. Prevention of induced colitis in mice by the ras antagonist farnesylthiosalicylic acid. 2012 Dig. Dis. Sci. pmid:21901261
Stärkel P et al. Ras inhibition in hepatocarcinoma by S-trans-trans-farnesylthiosalicyclic acid: association of its tumor preventive effect with cell proliferation, cell cycle events, and angiogenesis. 2012 Mol. Carcinog. pmid:21882255
Berrocal A et al. Quorum sensing activity in Ophiostoma ulmi: effects of fusel oils and branched chain amino acids on yeast-mycelial dimorphism. 2012 J. Appl. Microbiol. pmid:22519968
Falsetta ML et al. Novel antibiofilm chemotherapy targets exopolysaccharide synthesis and stress tolerance in Streptococcus mutans to modulate virulence expression in vivo. 2012 Antimicrob. Agents Chemother. pmid:22985885